Next Article in Journal
Coagulation Profiles of Pulmonary Arterial Hypertension Patients, Assessed by Non-Conventional Hemostatic Tests and Markers of Platelet Activation and Endothelial Dysfunction
Previous Article in Journal
Small Fibre Involvement in Multifocal Motor Neuropathy Explored with Sudoscan: A Single-Centre Experience
Previous Article in Special Issue
Development of a Clinical MALDI-ToF Mass Spectrometry Assay for SARS-CoV-2: Rational Design and Multi-Disciplinary Team Work
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Nitrogen-Doped Titanium Dioxide Nanoparticles Modified by an Electron Beam for Improving Human Breast Cancer Detection by Raman Spectroscopy: A Preliminary Study

Laboratory of Laser Molecular Spectroscopy, Institute of Applied Radiation Chemistry, Lodz University of Technology, Wroblewskiego 15, 93-590 Lodz, Poland
Submission received: 31 August 2020 / Revised: 22 September 2020 / Accepted: 24 September 2020 / Published: 26 September 2020

Abstract

:
Titanium dioxide (TiO2) is commonly used as a pigment in paints, paper products, polymer compositions, and cosmetic products, and even as a food additive or drug coating material. In recent times, it has also been used in photovoltaic cells, semiconductors, biomedical devices, and air purification. In this paper, the potential application of nitrogen-doped TiO2 nanoparticles modified by an electron beam for improving human breast cancer detection by Raman spectroscopy is presented. Raman spectroscopy (RS) is a promising noninvasive analytical technique in cancer detection that enables us to retrieve a molecular signature of the biochemical composition of cancerous tissue. However, RS still has some challenges in signal detection, mainly related to strong concurrent background fluorescence from the analyzed tissue. The Raman signal scattering is several orders of magnitude smaller than the fluorescence intensity, and strong fluorescence masks a much weaker Raman signal. The Raman results demonstrate that the N-doped TiO2 electron beam-irradiated nanoparticles amplify the Raman scattering. The intrinsic properties of the adsorbed molecules from human breast tissue and the surface properties of the N-doped TiO2 electron beam-irradiated nanoparticles (the excited electron–hole pair at the surface) have a significant effect on the enhanced Raman signal intensity.

Graphical Abstract

1. Introduction

Different spectroscopic techniques have been used to characterize human breast cancer tissue. Techniques such as magnetic resonance imaging (MRI) [1], infrared spectroscopy [2,3,4], and Raman spectroscopy [5,6,7,8,9,10,11,12,13,14,15] have been proven to be powerful methods in characterizing and understanding breast tissue. From a chemical point of view, biological specimens consist of complex mixtures of heterogeneous classes of molecules (e.g., water, lipids, proteins, carbohydrates, and nucleic acids).
Over the last decade, research has intensified in the area of detecting molecular changes from benign to neoplastic tissue. Currently, a low concentration of tumor biomarkers is still undetectable in an early-stage tumor. Here, an optical method of Raman spectroscopy is presented in order to allow the detection of cancerous changes in the human breast using N-doped TiO2 nanoparticles modified by electron beam irradiation. The advantages of the Raman technique are its high specificity and its versatility. It is a nondestructive method and requires, in general, only minimal or no sample preparation. Frozen biological specimens with thicknesses of as low as less than 10 µm can be analyzed. However, this optical method has two difficulties: first, it is not easily applicable to materials that exhibit fluorescence, and second, it has inherently poor signal-to-noise ratio. There are a few Raman signal enhancement mechanisms, which have been described in previous publications [16,17,18,19,20,21]. The inelastic light scattering process can be enhanced when the laser is within the molecular absorption bands of the sample. Excitation of this type is in resonance with the electronic transition and yields Raman scattering that is resonance-enhanced [22]. The second mechanism, electromagnetic enhancement, occurs when the incident laser light excites surface plasmons (electrons at the metal surface that collectively oscillate upon excitation), thereby creating an electromagnetic field extending up to 20 nm from the metallic substrate and enhancing Raman signals of exposed molecules [19]. The third mechanism is charge transfer, which transfers electrons between the analyte and metal/metal oxide semiconductor surface when the analyte directly contacts the surface.
In classical surface-enhanced Raman scattering (SERS) experiments, the metallic substrate is made of gold, silver, or copper metal. In this research, semiconductor nanoparticles (N-TiO2) modified by electron beam irradiation are used. Pristine titanium dioxide (TiO2) has been commonly used as a pigment in paint formulations, paper products, polymer compositions, and semiconductors in photovoltaic cells. Moreover, TiO2 has found applications in cosmetic products (e.g., sunscreen, toothpaste), food (e.g., chewing gum, confectionery such as when added to icing sugar), and cancer drugs (as a coating material in tablets with tamoxifen).
In this paper, a new approach for breast cancer diagnosis using N-doped TiO2 nanoparticles modified by an electron beam to enhance the Raman signal intensity is presented.

2. Materials and Methods

2.1. Chemical and Sample Preparation

All studies and procedures involving human tissue were carried out according to a protocol approved by the institutional Bioethical Committee at the Medical University of Lodz, Poland (No. RNN/31/11/KE). Tissue samples were collected from freshly excised surgical specimens. We used fresh bulk tissue samples and cryosectioned slices from the tumor mass and the tissue from the safety margin outside of the tumor mass obtained during breast surgery. The histological analysis was performed by professional medical doctors, board certified as pathologists, from the Medical University of Lodz, Department of Pathology, Chair of Oncology according to the standard histology protocols.
The bulk tissues or 6 µm cryosectioned slices of infiltrating ductal carcinoma (G2) without staining were closed in a glass vial or mounted on a BaF2 window for Raman spectroscopy investigation, respectively. First, pure samples were analyzed, and then the N-doped TiO2 nanoparticles modified by electron beam were added. N-doped TiO2 nanoparticles were manufactured by the methods described in our previous work [23]. Briefly, commercially available TiO2 P25 Degussa (80%:20% mixture of anatase and rutile; 20 nm) was doped with nitrogen by using the wet impregnation method: 5 g of TiO2 powder was sustained in 50 mL of urea ((NH2)2CO) water solution, stirred, and left under mild conditions for 2 weeks until the water evaporated. The urea concentration in solution was such that the atomic ratio of N:Ti in suspension was 1:1. The dried N-doped powder was irradiated with an electron beam (EB) from the linear accelerator ELU-6 MeV (USSR) at ambient temperature. The electron beam irradiation was performed in a continuous regime under the following conditions: pulse frequency = 20 Hz, pulse period = 4 ls, dose rate = 5.5 kGy/min. The total absorbed dose was 500 kGy.

2.2. Raman Measurements

The Raman spectra were recorded with a Ramanor U1000 (Horiba, JobinYvon) and a Spectra-Physics 2017-04S argon-ion laser operating at 514 nm with an output power of 52 mW (with a sample of 17 mW), a scanning step of 2 cm−1, and an integration time of 0.5 s. The Raman spectrometer Ramanor U1000 was equipped with a macrochamber that allows Raman scattering collection at 90° geometry. The laser spot was d = 500 µm in diameter.

2.3. UV-Vis Absorption Measurements

UV-Vis absorption spectra were recorded from powders suspended in OM 100 silicone oil and treated with 35 kHz ultrasound using a Bandelin Sonorex Digitec cleaner for 3 h. After that, treatment samples were centrifuged at around 4000 RPM for 10 minutes. The received supernatants were then easily separated from the samples using simple syringes, placed in 5 mm quartz cuvettes, and analyzed using a Perkin-Elmer 750 spectrometer.

3. Results

Before we present the results of the Raman spectroscopy for infiltrating ductal carcinoma (tissue sample from patient no. P89 from a database of over 250 patients) with and without the presence of nanoparticles, we first focus on the analysis of N-doped TiO2 electron beam (EB)-irradiated nanoparticles (NPs) by UV-Vis and Raman spectroscopy. Figure 1 shows the UV-Vis absorption and Raman spectra of N-doped TiO2 (N:Ti = 1:1) NPs EB-irradiated with a dose of 500 kGy. One can see in Figure 1A that an absorption band of TiO2 is shifted to the visible region upon N-doping, where efficient resonance conditions of Raman scattering for the excitation with 514 nm are present. A detailed description of the manufacturing and analysis of N-doped TiO2 NPs can be found in our previous work [23]. The Raman spectrum of N-doped TiO2 EB-irradiated NPs presented in Figure 1B shows characteristic bands at 398, 515, 639, 1010, and 1048 cm−1.
In a second step, we recorded and compared spectra from bulk (Figure 2) and 6 µm slices (Figure 3) of human breast noncancerous and cancerous tissue with and without the addition of N-doped TiO2 EB-irradiated NPs. Raman spectra with background fluorescence subtracted allow us to better appraise the effect of enhancement produced by N-doped TiO2 EB-irradiated NPs.
Figure 2 shows the Raman spectra of infiltrating ductal carcinoma (bulk tissue) with and without the addition of N-doped TiO2 EB-irradiated NPs. The Raman spectra of noncancerous bulk tissue without and with addition of N-doped TiO2 EB-irradiated NPs are dominated by spectral bands at 1004, 1156, 1265, 1440, 1518, 1654, 1746, 2727, 2850, 2888, and 3009 cm−1 and 398, 515, 639, 842, 963, 1004, 1010, 1048, 1078, 1156, 1199, 1265, 1300, 1375, 1440, 1474, 1518, 1586, 1654, 1746, 2727, 2850, 2888, and 3009 cm−1, respectively. Meanwhile, the spectrum of cancerous bulk tissue with the addition of N-doped TiO2 EB-irradiated NPs is dominated by bands at 398, 515, 639, 842, 916, 963, 1004, 1010, 1048, 1156, 1199, 1265, 1300, 1375, 1440, 1474, 1518, 1586, 1654, 2850, and 2894 cm−1. The Raman spectrum of cancerous bulk tissue reveals an absence of any Raman bands, and only strong fluorescence was observed.
The Raman spectra of 6 µm slices of noncancerous tissue without and with addition of N-doped TiO2 EB NPs are dominated by spectral bands at 842, 916, 1004, 1078, 1156, 1265, 1300, 1440, 1518, 1654, 1746, 2727, 2850, 2888, and 3009 cm−1 and 398, 515, 639, 842, 916, 963, 1004, 1010, 1048, 1078, 1265, 1300, 1440, 1474, 1654, 1746, 2727, 2850, 2888, 3009, and 3354 cm−1, respectively. Meanwhile, the 6 µm slices of cancerous tissue without and with addition of N-doped TiO2 EB NPs are dominated by bands at 842, 916, 963, 1004, 1140, 1199, 1265, 1300, 1440, 1474, 1586, 1654, 2850, 2908, and 2940 cm−1 and 398, 515, 639, 842, 916, 963, 1004, 1010, 1048, 1140, 1199, 1300, 1375, 1440, 1474, 1586, 1654, 2850, 2908, 2940, and 3354 cm−1, respectively.
Detailed peak allocations for carotenoids, lipids, carbohydrates, DNA, and proteins together with an indication of the observed changes with the presence or absence of N-doped TiO2 EB-irradiated NPs are shown in Table 1.
Figure 4 illustrates a comparison of background-subtracted Raman spectra for bulk tissues and 6 µm slices of noncancerous and infiltrating ductal carcinoma with and without the addition of N-doped TiO2 EB-irradiated NPs. The Raman spectra of 6 µm tissue slices reveal much better spectral quality compared to the Raman spectra of bulk tissues. It should be noted that by reducing the sample size to 6 µm, we reduced the number of molecules that emit fluorescence.

4. Discussion

The main aim of this preliminary work was to apply Raman spectroscopy as a noninvasive and nondestructive tool for probing human breast tissue in the presence and absence of N-doped TiO2 EB-irradiated nanoparticles.
The dominant modes in the Raman spectrum of N-doped TiO2 EB NPs presented in Figure 1B can be assigned to the Raman active modes of the anatase crystal: 398 (B1g(1)), 515 (A1g, B1g(2)), and 638 cm−1 (Eg(3)). The Raman peaks at 1010 and 1048 cm−1 originate from the bending mode (N–H) and new species generated by EB irradiation due to interactions with the polymorphic crystalline structure of TiO2 mixed with N-dopants [23], respectively.
The presented preliminary work shows that important differences between the noncancerous and cancerous human breast tissue were found in regions characteristic of vibrations of carotenoids (Raman bands at 1156 and 1518 cm−1), lipids (1078, 1300, 1440, 1654, 1746, 2850, 2888, and 3009 cm−1), and proteins (842, 1004, 1265, 1586, 1654, 2908, and 2940 cm−1) (Figure 4). Moreover, for noncancerous and cancerous tissue the effects of enhancement produced by N-doped TiO2 EB NPs, in bulk tissue and 6 µm slices of tissue, in comparison to results without the addition of these NPs, are 8.4 and 4.9 times higher and 15.4 and 1.4 times higher, respectively (calculated as the total integrated intensity of whole background-subtracted Raman spectra presented in Figure 2E,F and Figure 3E,F; noncancerous tissue: bulk (w/o NT) = 440,958 cts/s, bulk (with NT) = 3,708,312 cts/s, 6 µm slice (w/o NT) = 1,644,266 cts/s, 6 µm slice (with NT) = 2,167,831 cts/s; cancerous tissue: bulk (w/o NT) = 197,437 cts/s, bulk (with NT) = 3,033,796 cts/s, 6 µm slice (w/o NT) = 1,188,652 cts/s, 6 µm slice (with NT) = 1,658,370 cts/s). We believe that the explanation for the observed Raman signal enhancement might lie in the N-doped TiO2 forms; thus, we used electron–hole pair theory for the explanation [23,27]. The TiO2 forms belonged to the n-type semiconductor, which contained many electron–hole (e–h) pairs. The energy gap restricted the transfer of electron–hole pairs when it was excited by the photon. The excitation of electron–hole pairs at the surface of TiO2 was possibly transferred via σ–π coordinate bonds and electrostatic force fields between N and Ti to excitations of the adsorbed molecules from breast tissue samples, especially from carotenoids and lipids. The excited adsorbed molecules created molecular fluctuation in the interim, thus leading to the enhancement of Raman scattering. On the other hand, electrons can be transferred from excited states of carotenoids to the conduction band of semiconductor particles and cause enhanced photodegradation and photoisomerization of carotenoids, depending on the properties of both the carotenoids and the semiconductor [28]. It is interesting to note that the photocatalytic reduction of carotenoids was observed only for 6 µm human breast tissue slices (Figure 4) in comparison to bulk tissue samples.
Polyakov et al. showed that the observed enhancement of the photocatalytic efficiency for carotenoid complexes with TiO2, as measured by the quantum yield of the desired spin adducts, arises specifically from a decrease in the rate constant for the back electron transfer to the carotenoid radical cation. Polyakov’s results are important for a variety of TiO2 applications, namely, photodynamic therapy and the design of artificial light-harvesting, photo-redox, and catalytic devices [29].
Aswini et al. evaluated the cytotoxicity of TiO2 nanoparticles against human lung carcinoma cells (A549 cell line). They observed anti-lung cancer activity of TiO2 nanoparticles at an IC50 value of 53.65 µg/mL. They proposed a possible mechanism involved in the cancer cell death: ROS (reactive oxygen species) play the main important role in eukaryotic cell death by TiO2 nanoparticles. ROS originate from environmental irritants, cellular sources mainly in mitochondria, and NADPH oxidase [30]. This anti-cancer activity might be associated with direct effects of NPs on cells, stimulating the production of free radicals and other oxidants. However, Fu et al. showed that nano-TiO2 increased ROS production in UV-exposed cells [31]. Furthermore, NP-derived oxidative stress in vivo may involve mitochondria or NAD(P)H oxidase. Highly reactive hydroxyl acts as a powerful oxidant, resulting in oxidative DNA damage to both single- and double-stranded DNA [30]. Fujiwara et al. found that the oxidative stress produced in response to administration of 6 nm anatase titanium dioxide nanoparticles (on mouse lung and colon cancer cells) was enhanced by high glucose concentrations, acidic pH, hypoxia, high temperature, and the presence of advanced glycation end products [32].
Further studies should be performed to determine the anti-tumor properties of N-doped TiO2 EB-irradiated nanoparticles and their application in photodynamic therapy.

5. Conclusions

In conclusion, our previous study showed that Raman spectroscopy might be a rapid and highly sensitive detection tool for breast cancer diagnosis [11,12,13]. The presented findings are consistent with those of our previous work and show that the application of N-doped TiO2 EB-irradiated NPs on breast cancer tissue improves the detection of Raman signals (enhancing it by up to 15.4 times), thus increasing the applicability of this technique in the analysis of intraoperative specimens. Further in vitro studies should be carried out to determine the anticancer properties of N-doped TiO2 EB-irradiated nanoparticles on cellular activities (e.g., life-cycle processes) and their photosensitizing properties in photodynamic therapy application.

Funding

This research was funded by the Foundation for Polish Science, grant number START-2014, and the National Science Centre of Poland (Narodowe Centrum Nauki, UMO-2019/33/B/ST4/01961).

Acknowledgments

The author thanks the entire surgery and pathology staff at the Medical University of Lodz and Synevo for providing the biological samples and performing histopathology examination, with special thanks addressed to Jacek Musiał and Radzisław Kordek. The author kindly thanks Paweł Wroński and Magdalena Szadkowska-Nicze for sharing the N-doped TiO2 EB-irradiated nanoparticles and UV-Vis absorption analysis.

Conflicts of Interest

The author declares no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

References

  1. Radhakrishna:, S.; Agarwal, S.; Parikh, P.M.; Kaur, K.; Panwar, S.; Sharma, S.; Dey, A.; Saxena, K.K.; Chandra, M.; Sud, S. Role of magnetic resonance imaging in breast cancer management. South Asian J. Cancer 2018, 7, 69–71. [Google Scholar] [CrossRef]
  2. Su, K.-Y.; Lee, W.-L. Fourier Transform Infrared Spectroscopy as a Cancer Screening and Diagnostic Tool: A Review and Prospects. Cancers 2020, 12, 115. [Google Scholar] [CrossRef] [Green Version]
  3. Backhaus, J.; Mueller, R.; Formanski, N.; Szlama, N.; Meerpohl, H.-G.; Eidt, M.; Bugert, P. Diagnosis of breast cancer with infrared spectroscopy from serum samples. Vib. Spectrosc. 2010, 52, 173–177. [Google Scholar] [CrossRef]
  4. Elmi, F.; Movaghar, A.F.; Elmi, M.M.; Alinezhad, H.; Nikbakhsh, N. Application of FT-IR spectroscopy on breast cancer serum analysis. Spectrochim. Acta Part A Mol. Biomol. Spectrosc. 2017, 187, 87–91. [Google Scholar] [CrossRef] [PubMed]
  5. Lyng, F.M.; Traynor, D.; Nguyen, T.N.Q.; Meade, A.D.; Rakib, F.; Al-Saady, R.; Goormaghtigh, E.; Al-Saad, K.; Ali, M.H. Discrimination of breast cancer from benign tumours using Raman spectroscopy. PLoS ONE 2019, 14, e0212376. [Google Scholar] [CrossRef]
  6. Sabtu, S.N.; Sani, S.F.A.; Bradley, D.A.; Looi, L.M.; Osman, Z. A review of the applications of Raman spectroscopy for breast cancer tissue diagnostic and their histopathological classification of epithelial to mesenchymal transition. J. Raman Spectrosc. 2020, 51, 380–389. [Google Scholar] [CrossRef]
  7. Haka, A.S.; Shafer-Peltier, K.E.; Fitzmaurice, M.; Crowe, J.; Dasari, R.R.; Feld, M.S. Diagnosing breast cancer by using Raman spectroscopy. Proc. Natl. Acad. Sci. USA 2005, 102, 12371–12376. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  8. Haka, A.S.; Volynskaya, Z.; Gardecki, J.A.; Nazemi, J.; Shenk, R.; Wang, N.; Dasari, R.R.; Fitzmaurice, M.; Feld, M.S. Diagnosing breast cancer using Raman spectroscopy: Prospective analysis. J. Biomed. Opt. 2009, 14, 054023. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  9. Lazaro-Pacheco, D.; Shaaban, A.M.; Rehman, S.; Rehman, I. Raman spectroscopy of breast cancer. Appl. Spectrosc. Rev. 2020, 55, 439–475. [Google Scholar] [CrossRef]
  10. Abramczyk, H.; Surmacki, J.; Kopeć, M.; Olejnik, A.K.; Kaufman-Szymczyk, A.; Fabianowska-Majewska, K. Epigenetic changes in cancer by Raman imaging, fluorescence imaging, AFM and scanning near-field optical microscopy (SNOM). Acetylation in normal and human cancer breast cells MCF10A, MCF7 and MDA-MB-231. Analyst 2016, 141, 5646–5658. [Google Scholar] [CrossRef]
  11. Abramczyk, H.; Brozek-Pluska, B.; Surmacki, J.; Jablonska-Gajewicz, J.; Kordek, R. Raman “optical biopsy” of human breast cancer. Prog. Biophys. Mol. Biol. 2012, 108, 74–81. [Google Scholar] [CrossRef] [PubMed]
  12. Surmacki, J.; Musial, J.; Kordek, R.; Abramczyk, H. Raman imaging at biological interfaces: Applications in breast cancer diagnosis. Mol. Cancer 2013, 12, 48. [Google Scholar] [CrossRef] [Green Version]
  13. Abramczyk, H.; Imiela, A.; Brożek-Płuska, B.; Kopeć, M.; Surmacki, J.; Śliwińska, A. Aberrant Protein Phosphorylation in Cancer by Using Raman Biomarkers. Cancers 2019, 11, 2017. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  14. Matousek, P.; Stone, N. Prospects for the diagnosis of breast cancer by noninvasive probing of calcifications using transmission Raman spectroscopy. J. Biomed. Opt. 2007, 12, 024008. [Google Scholar] [CrossRef] [PubMed]
  15. Gao, P.; Han, B.; Du, Y.; Zhao, G.; Yu, Z.; Xu, W.; Zheng, C.; Fan, Z. The Clinical Application of Raman Spectroscopy for Breast Cancer Detection. Available online: https://www.hindawi.com/journals/jspec/2017/5383948/ (accessed on 3 August 2020).
  16. Demirel, G.; Usta, H.; Yilmaz, M.; Celik, M.; Alidagi, H.A.; Buyukserin, F. Surface-enhanced Raman spectroscopy (SERS): An adventure from plasmonic metals to organic semiconductors as SERS platforms. J. Mater. Chem. C 2018, 6, 5314–5335. [Google Scholar] [CrossRef]
  17. Kim, J.; Jang, Y.; Kim, N.-J.; Kim, H.; Yi, G.-C.; Shin, Y.; Kim, M.H.; Yoon, S. Study of Chemical Enhancement Mechanism in Non-plasmonic Surface Enhanced Raman Spectroscopy (SERS). Front. Chem. 2019, 7, 582. [Google Scholar] [CrossRef] [Green Version]
  18. Pilot, R.; Signorini, R.; Durante, C.; Orian, L.; Bhamidipati, M.; Fabris, L. A Review on Surface-Enhanced Raman Scattering. Biosensors 2019, 9, 57. [Google Scholar] [CrossRef] [Green Version]
  19. Halvorson, R.A.; Vikesland, P.J. Surface-Enhanced Raman Spectroscopy (SERS) for Environmental Analyses. Environ. Sci. Technol. 2010, 44, 7749–7755. [Google Scholar] [CrossRef]
  20. McNay, G.; Eustace, D.; Smith, W.E.; Faulds, K.; Graham, D. Surface-Enhanced Raman Scattering (SERS) and Surface-Enhanced Resonance Raman Scattering (SERRS): A Review of Applications. Appl. Spectrosc. 2011, 65, 825–837. [Google Scholar] [CrossRef]
  21. Brozek-Pluska, B.; Kopec, M.; Surmacki, J. Surface-Enhanced Raman Spectroscopy Analysis of Human Breast Cancer via Silver Nanoparticles: An Examination of Fabrication Methods. Available online: https://www.hindawi.com/journals/jspec/2018/4893274/ (accessed on 3 August 2020).
  22. Asher, S.A. UV Resonance Raman Spectroscopy for Analytical, Physical, and Biophysical Chemistry. Anal. Chem. 1993, 65, 59A–66A. [Google Scholar] [CrossRef]
  23. Surmacki, J.; Wroński, P.; Szadkowska-Nicze, M.; Abramczyk, H. Raman spectroscopy of visible-light photocatalyst–Nitrogen-doped titanium dioxide generated by irradiation with electron beam. Chem. Phys. Lett. 2013, 566, 54–59. [Google Scholar] [CrossRef]
  24. Ur Rehman, I.; Movasaghi, Z.; Rehman, S. Vibrational Spectroscopy for Tissue Analysis; CRC Press: Boca Raton, FL, USA, 2013; ISBN 9781439836088. [Google Scholar]
  25. De Gelder, J.; De Gussem, K.; Vandenabeele, P.; Moens, L. Reference database of Raman spectra of biological molecules. J. Raman Spectrosc. 2007, 38, 1133–1147. [Google Scholar] [CrossRef]
  26. Surmacki, J.M.; Woodhams, B.J.; Haslehurst, A.; Ponder, B.A.J.; Bohndiek, S.E. Raman micro-spectroscopy for accurate identification of primary human bronchial epithelial cells. Sci. Rep. 2018, 8, 12604. [Google Scholar] [CrossRef]
  27. Yamada, Y.; Kanemitsu, Y. Determination of electron and hole lifetimes of rutile and anatase TiO2 single crystals. Appl. Phys. Lett. 2012, 101, 133907. [Google Scholar] [CrossRef] [Green Version]
  28. Gao, F.G.; Bard, A.J.; Kispert, L.D. Photocurrent generated on a carotenoid-sensitized TiO2 nanocrystalline mesoporous electrode. J. Photochem. Photobiol. A Chem. 2000, 130, 49–56. [Google Scholar] [CrossRef]
  29. Polyakov, N.E.; Leshina, T.V.; Meteleva, E.S.; Dushkin, A.V.; Konovalova, T.A.; Kispert, L.D. Enhancement of the photocatalytic activity of TiO2 nanoparticles by water-soluble complexes of carotenoids. J. Phys. Chem. B 2010, 114, 14200–14204. [Google Scholar] [CrossRef]
  30. Aswini, R.; Murugesan, S.; Kannan, K. Bio-engineered TiO2 nanoparticles using Ledebouria revoluta extract: Larvicidal, histopathological, antibacterial and anticancer activity. Int. J. Environ. Anal. Chem. 2020, 1–11. [Google Scholar] [CrossRef]
  31. Fu, L.; Hamzeh, M.; Dodard, S.; Zhao, Y.H.; Sunahara, G.I. Effects of TiO2 nanoparticles on ROS production and growth inhibition using freshwater green algae pre-exposed to UV irradiation. Environ. Toxicol. Pharm. 2015, 39, 1074–1080. [Google Scholar] [CrossRef] [PubMed]
  32. Fujiwara, R.; Luo, Y.; Sasaki, T.; Fujii, K.; Ohmori, H.; Kuniyasu, H. Cancer Therapeutic Effects of Titanium Dioxide Nanoparticles Are Associated with Oxidative Stress and Cytokine Induction. Pathobiology 2015, 82, 243–251. [Google Scholar] [CrossRef]
Figure 1. Electronic absorption (A) and Raman (B) spectra of N-doped TiO2 (N:Ti =1:1) nanoparticles electron beam-irradiated with a dose of 500 kGy.
Figure 1. Electronic absorption (A) and Raman (B) spectra of N-doped TiO2 (N:Ti =1:1) nanoparticles electron beam-irradiated with a dose of 500 kGy.
Diagnostics 10 00757 g001
Figure 2. Raman spectra of infiltrating ductal carcinoma (bulk tissue) with and without the addition of N-doped TiO2 (N:Ti = 1:1) nanoparticles electron beam-irradiated with a dose of 500 kGy. Subsets (E) and (F) show a comparison of Raman spectra after background subtraction marked in blue lines on raw Raman spectra (AD). Raman bands attributed to N-doped TiO2 electron beam (EB)-irradiated nanoparticles (NPs) are marked with an asterisk (*).
Figure 2. Raman spectra of infiltrating ductal carcinoma (bulk tissue) with and without the addition of N-doped TiO2 (N:Ti = 1:1) nanoparticles electron beam-irradiated with a dose of 500 kGy. Subsets (E) and (F) show a comparison of Raman spectra after background subtraction marked in blue lines on raw Raman spectra (AD). Raman bands attributed to N-doped TiO2 electron beam (EB)-irradiated nanoparticles (NPs) are marked with an asterisk (*).
Diagnostics 10 00757 g002
Figure 3. Raman spectra of infiltrating ductal carcinoma (6 µm slice) with and without the addition of N-doped TiO2 (N:Ti = 1:1) nanoparticles electron beam-irradiated with a dose of 500 kGy. Subsets (E) and (F) show a comparison of Raman spectra after background subtraction marked in blue lines on raw Raman spectra (AD). Raman bands attributed to N-doped TiO2 EB-irradiated NPs are marked with an asterisk (*).
Figure 3. Raman spectra of infiltrating ductal carcinoma (6 µm slice) with and without the addition of N-doped TiO2 (N:Ti = 1:1) nanoparticles electron beam-irradiated with a dose of 500 kGy. Subsets (E) and (F) show a comparison of Raman spectra after background subtraction marked in blue lines on raw Raman spectra (AD). Raman bands attributed to N-doped TiO2 EB-irradiated NPs are marked with an asterisk (*).
Diagnostics 10 00757 g003
Figure 4. Comparison of Raman spectra for bulk tissues (AD) and 6 µm slices (E,F) of infiltrating ductal carcinoma with (B,D,F) and without (A,C,E) addition of N-doped TiO2 (N:Ti = 1:1) nanoparticles electron beam-irradiated with a dose of 500 kGy. Raman spectra are presented after background subtraction. Raman bands attributed to N-doped TiO2 EB-irradiated NPs are marked with an asterisk (*).
Figure 4. Comparison of Raman spectra for bulk tissues (AD) and 6 µm slices (E,F) of infiltrating ductal carcinoma with (B,D,F) and without (A,C,E) addition of N-doped TiO2 (N:Ti = 1:1) nanoparticles electron beam-irradiated with a dose of 500 kGy. Raman spectra are presented after background subtraction. Raman bands attributed to N-doped TiO2 EB-irradiated NPs are marked with an asterisk (*).
Diagnostics 10 00757 g004
Table 1. Peak allocations for carotenoids, lipids, carbohydrates, DNA, and proteins [12,24,25,26] together with an indication of the observed changes with and without the addition of N-doped TiO2 electron beam-irradiated nanoparticles (NPs).
Table 1. Peak allocations for carotenoids, lipids, carbohydrates, DNA, and proteins [12,24,25,26] together with an indication of the observed changes with and without the addition of N-doped TiO2 electron beam-irradiated nanoparticles (NPs).
Frequency (cm−1)AssignmentNoncancerous TissueCancerous Tissue
Bulk Tissue6 µm SliceBulk Tissue6 µm Slice
w/owith NPsw/owith NPsw/owith NPsw/owith NPs
398N-TiO2 EB-+-+-+-+
515N-TiO2 EB-+-+-+-+
639N-TiO2 EB-+-+-+-+
842Tryptophan, proteins-+++-+++
916Proline, hydroxyproline, glycogen, lactic acid--++-+++
963C-O deoxyribose, C-C DNA-+-+-+++
1004Phenylalanine, proteins, and carotenoids, CH3 rocking coupled with C-C stretching++++-+++
1010N-TiO2 EB-+-+-+-+
1048N-TiO2 EB-+-+-+-+
1078Phospholipids, stretching (C-C) or stretching (C-O)-+++----
1140Adenine (ring breathing modes of the DNA/RNA bases)------++
1156Carotenoids, C-C stretching+++--+--
1199Nucleic acids and phosphates (P=O)-+---+++
1265Phospholipids, PO2 antisymmetric stretching, =C-H in plane deformation, Amide III (of proteins in -helix conformation)++++-+--
1300Lipids, phospholipids, H-C= deformation-+++-+++
1375Proteins, C C-H bending mixed with C-N stretching and N-H in plane bending, adenine (ring breathing modes of the DNA/RNA bases)-+---+-+
1440Lipids, CH2 and CH3 deformation vibrations++++-+++
1474DNA, ring breathing mode-+-+-+++
1518Carotenoids, C=C stretching+++--+--
1586Tryptophan, NADH, cytochrome C, C-C stretching, C-H bending-+---+++
1654Lipids and proteins (amide I), C=C stretching++++-+++
1746Lipids, C=O stretching++++----
2727Carotenoids, overtone++++----
2850Lipids, fatty acids, saturated bonds of lipids, symmetric stretching of CH2++++-+++
2888Lipids, fatty acids, (CH2)C-H antisymmetric stretching++++----
2894, 2908Symmetric stretching of CH3-----+++
2940Proteins, asymmetric stretching of CH3, C-H stretching------++
3009Fatty acids, unsaturated bonds of lipids, H -C=C stretching++++----
3354Water, DNA, proteins,
O-N, O-H stretching
---+---+

Share and Cite

MDPI and ACS Style

Surmacki, J. Nitrogen-Doped Titanium Dioxide Nanoparticles Modified by an Electron Beam for Improving Human Breast Cancer Detection by Raman Spectroscopy: A Preliminary Study. Diagnostics 2020, 10, 757. https://0-doi-org.brum.beds.ac.uk/10.3390/diagnostics10100757

AMA Style

Surmacki J. Nitrogen-Doped Titanium Dioxide Nanoparticles Modified by an Electron Beam for Improving Human Breast Cancer Detection by Raman Spectroscopy: A Preliminary Study. Diagnostics. 2020; 10(10):757. https://0-doi-org.brum.beds.ac.uk/10.3390/diagnostics10100757

Chicago/Turabian Style

Surmacki, Jakub. 2020. "Nitrogen-Doped Titanium Dioxide Nanoparticles Modified by an Electron Beam for Improving Human Breast Cancer Detection by Raman Spectroscopy: A Preliminary Study" Diagnostics 10, no. 10: 757. https://0-doi-org.brum.beds.ac.uk/10.3390/diagnostics10100757

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop